Clinical Trial: Bevacizumab for Primary Pterygium Treatment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Conjunctival Autografting Alone or Combined With Subconjunctival Bevacizumab for Primary Pterygium Treatment.
Brief Summary: The aim of this study was to investigate the efficacy and safety of subconjunctival bevacizumab application as an adjuvant therapy for primary pterygium.
Detailed Summary:
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana
Current Primary Outcome: Pterygium recurrence [ Time Frame: One point. ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Conjunctival ischemia [ Time Frame: Ischemia is measured at 24 h, 1 week, 15 days, six months and one year postoperative ]
Original Secondary Outcome: Same as current
Information By: Instituto de Oftalmología Fundación Conde de Valenciana
Dates:
Date Received: September 11, 2012
Date Started: March 2010
Date Completion:
Last Updated: December 5, 2013
Last Verified: December 2013